Currinbell6721
The peg shaped PMLI was seen in 81 (98.87%) patients and barrel shaped was present in 1 (1.22%) patient. The malformed PMLIs was found to be unilateral in 38 (46.3%) and bilateral in 44 (53.7%) patients, with more common presence on both sides 44 (53.7%) followed by right side 20 (24.4%) and left side 18 (22.0%).
The subjects having predominant developmental malformation in case of permanent maxillary lateral incisor was peg-shaped permanent maxillary lateral incisor.
The subjects having predominant developmental malformation in case of permanent maxillary lateral incisor was peg-shaped permanent maxillary lateral incisor.
Melasma is an acquired cutaneous disorder characterized by hyperpigmentation of the face predominantly affecting the areas exposed to direct sun light. The triple combination cream, i.e., a mid-potency corticosteroid (Fluocinolone acetonide 0.01%), a retinoid (Tretinoin 0.05%), and Hydroquinone 4% is one of the widely used topical medicament for melasma treatment world over. Tranexamic acid is another agent found to be effective in melasma treatment when used topically, intra-lesionally or orally. This study has been conducted to compare mean decrease in Melasma Area Severity Index (MASI) score when tranexamic acid is combined with triple combination cream versus triple combination cream alone for melasma treatment.
A randomized controlled trial was conducted in a tertiary care hospital of Pakistan. Sixty-three patients of melasma who met the inclusion criteria and gave written informed consent for the study were enrolled. UMI-77 Bcl-2 inhibitor These patients were randomly divided into 2 treatment groups. Group A was given trire when used in combination with topical triple regimen. It may have a role as an adjuvant to topical triple combination cream.
Keratoconus (KC) is a bilateral, asymmetric, corneal disorder that is characterized by progressive thinning, steepening, and potential scarring. In the early stages of keratoconus treatment can be modulated with contact lenses but once it reaches to scarring, penetrating keratoplasty (PK) is the standard procedure of care. As there is not enough published data on penetrating keratoplasty in Pakistan and also early visual outcomes post keratoconus keratoplasty have not been established so this study would be beneficial for further research and opting keratoplasty as a procedure for management of advance keratoconus. To determine the frequency of improvement in the visual acuity six months after penetrating keratoplasty in patiens of Keratoconus.
Sixty-five eyes of 65 patients fulfilling the inclusion criteria were taken from the Outdoor Clinic of Layton Rahmatulla Benevolent Trust Free Eye and Cancer Hospital. Informed consent was taken and socio-demographic data (name, age, gender, address and contact number) was also recorded. Examination included Visual Acuity with Snellen's Chart with assessment of light projection in patients with Visual Acuity hand movements or light perception. Slit lamp examination with Haag Streit BQ 900 Slit lamp for assessing the condition of cornea was done. Indirect ophthalmoscopy was performed using 90D lens for fundus examination. B-scan (ocular ultrasonography) with Alcon B-scan was done where fundus examination was not possible. Standard surgical procedure of Penetrating Keratoplasty was carried out on all patients. Visual Acuity was recorded on Day 7, 90 and 180 after the surgery.
Penetrating Keratoplasty is a safe and reliable procedure for improvement in visual acuity of patients with keratoconus and should be conducted on mass level to avoid blindness caused by keratoconus.
Penetrating Keratoplasty is a safe and reliable procedure for improvement in visual acuity of patients with keratoconus and should be conducted on mass level to avoid blindness caused by keratoconus.
During the pandemic, disruption of work schedule and constant health risks causes physician burnout. This study aims to identify Burnout in physicians working in COVID ICU and isolation Ward.
A cross-sectional study was conducted on 200 physicians who had worked in either COVID ICU or Isolation ward. A survey of 23 questions was designed to assess the work-related Burnout using the Copenhagen burnout inventory and the implementation of NIH guidelines.
Among the 200 physicians, 151 (75.5%) were well informed of the guidelines, of which 52 (34.4%) participants believed the guidelines were not sufficient. These 34.4% of individuals showed a mean burnout score of 70.05% (p-value 0.001). Medical registrars and Medical Officers suffered the highest burnout mean percentage score of 76% and 72.42%, respectively. 89 (44.5%) individuals arranged PPE suits on their own and suffered a burnout score of 71.3% ±14.35 (p-value <0.001). Seventy-two (36%) claimed their administration was not cooperative in resolve saflp elevate work-related burnout in physicians working in the ICU and isolation ward.
Sudden sensorineural hearing loss (SSNHL) is considered an otologic emergency globally. Aetiology is unknown in most cases but still the disease is believed to be caused by inflammation of the cochlea; therefore, steroids are considered beneficial due to their anti-inflammatory effect.
This study was conducted on 62 patients of sudden sensorineural hearing loss (SSNHL) in Ayub Medical Complex, Abbottabad. The patients were given prednisolone and their response to the therapy was monitored. Factors like age of the patient, gender, degree of hearing loss and duration of symptoms at initial presentation were recorded and their effect of response of the patient was also noted.
The research subjects were 62 patients. Majority of the patients suffered from moderate to moderately severe hearing loss. Age and gender did not influence the response to the treatment. While the patients who presented earlier after the onset of disease and the patients who had milder degree of hearing loss at presentation had a better response to therapy.
Oral corticosteroid therapy is a good therapeutic option for the treatment of sudden sensorineural hearing loss (SSHNL). The response to therapy is better in patients with milder hearing loss and those who present early to the otologist for treatment.
Oral corticosteroid therapy is a good therapeutic option for the treatment of sudden sensorineural hearing loss (SSHNL). The response to therapy is better in patients with milder hearing loss and those who present early to the otologist for treatment.